PriceTargets.com logo

NYSE:GL - Globe Life Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $110.43
  • Forecasted Upside: 8.74 %
  • Number of Analysts: 6
  • Breakdown:
  • 2 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$101.55 As of 08/11/2022 01:00 AM ET
▼ -0.04 (-0.04%)

This chart shows the closing price for GL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Globe Life Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GL

Analyst Price Target is $110.43
▲ +8.74% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Globe Life in the last 3 months. The average price target is $110.43, with a high forecast of $130.00 and a low forecast of $85.00. The average price target represents a 8.74% upside from the last price of $101.55.

This chart shows the closing price for GL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 polled investment analysts is to hold stock in Globe Life. This rating has held steady since January 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
2/17/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
5/18/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
8/16/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/14/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
2/12/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
5/13/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
7/12/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
8/11/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/11/2022JPMorgan Chase & Co.Boost Price Target$108.00 ➝ $112.00N/A
7/8/2022Piper SandlerBoost Price TargetOverweight$119.00 ➝ $121.00N/A
6/15/2022Evercore ISIUpgradeIn-Line ➝ Outperform$105.00 ➝ $112.00High
2/22/2022Morgan StanleyBoost Price TargetUnderweight$105.00 ➝ $107.00Medium
1/25/2022Jefferies Financial GroupInitiated CoverageHold$106.00Low
1/21/2022Wolfe ResearchInitiated CoverageUnderperform$85.00Medium
1/12/2022Piper SandlerUpgradeNeutral ➝ Overweight$105.00 ➝ $117.00High
1/7/2022Morgan StanleyBoost Price TargetUnderweight$103.00 ➝ $105.00Medium
1/5/2022Piper SandlerBoost Price TargetUnderweight ➝ Underweight$97.00 ➝ $105.00Medium
11/18/2021Morgan StanleyLower Price TargetUnderweight$105.00 ➝ $103.00Low
10/19/2021Credit Suisse GroupLower Price TargetOutperform$135.00 ➝ $130.00Low
7/8/2021Piper SandlerLower Price TargetNeutral$105.00 ➝ $100.00High
6/7/2021Credit Suisse GroupBoost Price TargetOutperform$122.00 ➝ $135.00Low
5/19/2021Morgan StanleyBoost Price TargetUnderweight$100.00 ➝ $105.00Low
4/5/2021JPMorgan Chase & Co.Boost Price TargetCautious ➝ Overweight$99.00 ➝ $103.00Low
4/1/2021Morgan StanleyBoost Price TargetUnderweight$95.00 ➝ $100.00Medium
2/25/2021Morgan StanleyBoost Price TargetUnderweight$93.00 ➝ $95.00Medium
1/15/2021Morgan StanleyBoost Price TargetUnderweight$92.00 ➝ $93.00Low
1/6/2021Piper SandlerBoost Price TargetNeutral$87.00 ➝ $95.00N/A
12/4/2020Credit Suisse GroupBoost Price TargetOutperform$109.00 ➝ $122.00Medium
11/18/2020Morgan StanleyBoost Price TargetUnderweight$86.00 ➝ $92.00Medium
10/22/2020JPMorgan Chase & Co.Boost Price TargetOverweight$97.00 ➝ $99.00High
10/22/2020Morgan StanleyBoost Price TargetUnderweight$84.00 ➝ $86.00High
10/6/2020Morgan StanleyBoost Price TargetUnderweight$82.00 ➝ $84.00Medium
8/20/2020Morgan StanleyBoost Price TargetUnderweight$80.00 ➝ $82.00Medium
8/12/2020Credit Suisse GroupReiterated RatingBuyLow
7/23/2020Credit Suisse GroupReiterated RatingBuyLow
7/23/2020Morgan StanleyBoost Price TargetUnderweight$78.00 ➝ $80.00High
7/6/2020Morgan StanleyBoost Price TargetUnderweight$72.00 ➝ $78.00High
7/2/2020Piper SandlerLower Price TargetNeutral$87.00 ➝ $77.00High
6/5/2020Piper SandlerInitiated CoverageNeutral$87.00High
4/24/2020SunTrust BanksLower Price TargetHold$108.00 ➝ $79.00Low
4/23/2020Morgan StanleyLower Price TargetUnderweight$73.00 ➝ $72.00Medium
3/17/2020Morgan StanleyLower Price TargetUnderweight$91.00 ➝ $73.00High
1/7/2020BarclaysReiterated RatingSell$84.00Low
10/10/2019UBS GroupLower Price TargetSell$85.00 ➝ $84.00Low
9/20/2019Credit Suisse GroupInitiated CoverageOutperform$114.00Low
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.19 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/14/2022
  • 3 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/13/2022
  • 1 very positive mentions
  • 25 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/15/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/14/2022
  • 1 very positive mentions
  • 28 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/14/2022
  • 3 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/13/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/13/2022
  • 3 very positive mentions
  • 30 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/12/2022

Current Sentiment

  • 3 very positive mentions
  • 30 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Globe Life logo
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Read More

Today's Range

Now: $101.55
Low: $101.28
High: $102.00

50 Day Range

MA: $97.69
Low: $88.38
High: $101.59

52 Week Range

Now: $101.55
Low: $85.25
High: $108.61

Volume

527,039 shs

Average Volume

447,308 shs

Market Capitalization

$9.90 billion

P/E Ratio

14.45

Dividend Yield

0.82%

Beta

0.88

Frequently Asked Questions

What sell-side analysts currently cover shares of Globe Life?

The following Wall Street analysts have issued reports on Globe Life in the last twelve months: Credit Suisse Group AG, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, StockNews.com, and Wolfe Research.
View the latest analyst ratings for GL.

What is the current price target for Globe Life?

7 Wall Street analysts have set twelve-month price targets for Globe Life in the last year. Their average twelve-month price target is $110.43, suggesting a possible upside of 8.7%. Credit Suisse Group AG has the highest price target set, predicting GL will reach $130.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $85.00 for Globe Life in the next year.
View the latest price targets for GL.

What is the current consensus analyst rating for Globe Life?

Globe Life currently has 2 sell ratings, 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GL, but not buy more shares or sell existing shares.
View the latest ratings for GL.

What other companies compete with Globe Life?

Other companies that are similar to Globe Life include Reinsurance Group of America, Lincoln National, Aegon, Voya Financial and Primerica. Learn More about companies similar to Globe Life.

How do I contact Globe Life's investor relations team?

Globe Life's physical mailing address is 3700 South Stonebridge Drive, McKinney TX, 75070. The company's listed phone number is (972) 569-4000 and its investor relations email address is [email protected] The official website for Globe Life is www.globelifeinsurance.com. Learn More about contacing Globe Life investor relations.